schiff gmp compliance key points
TRANSCRIPT
-
8/12/2019 Schiff GMP Compliance Key Points
1/15
KEY POINTS FOR
GMP-PRODUCTIONCOMPLIANCE
KEY POINTS FOR GMP
ROBERT SCHIFF, PHD, RAC, CQA
PRESIDENT AND CEO
SCHIFF &COMPANY
1129 BLOOMFIELD AVENUE
WEST CALDWELL, NJ 07006
973-227-1830
ESTABLISHED IN 1982
-
8/12/2019 Schiff GMP Compliance Key Points
2/15
NEED FOR GMP REGULATION
Adulteration Product not made according to master record
Misbranding Labeling not correct
Claims not appropriate
Safety Too much, too little, not sterile
Effectiveness Product does not work
WHAT IS COMPLIANCE
Conformity
Obedience
Fulfillment
-
8/12/2019 Schiff GMP Compliance Key Points
3/15
GMP COMPLIANCE
DRUGS
21 CFR 211
DEVICES
21 CFR 820
BIOLOGICS
21 CFR 211 and 600
FOOD 21 CFR 110
SUPPLEMENTS
21 CFR 111
ICH GUIDELINES
ICH Q Series
Q1A-Q1F
Q2A-Q2B
Q3A-Q3C
Q4
Q5A-Q5E
Q6A-Q6B
Q7A
Q8-Q10
-
8/12/2019 Schiff GMP Compliance Key Points
4/15
PRODUCTION
21 CFR 210.3 (12)
Manufacture, processing, packing, or
holding of a drug product includes
packaging and labeling operations, testing,
and quality control of drug products.
QUALITY CONTROL
21 CFR 211.22 (a) There shall be a quality control unit that shall have the
responsibility and authority to approve or reject all
components, drug product containers, closures, in-process
materials, packaging material, labeling, and drug products,
and the authority to review production records to assure
that no errors have occurred or, if errors have occurred, that
they have been fully investigated. The quality control unit
shall be responsible for approving or rejecting drug products
manufactured, processed, packed, or held under contract byanother company.
-
8/12/2019 Schiff GMP Compliance Key Points
5/15
DOCUMENTATION
Standard operating procedures
Quality and/or operations manual
Validations and verifications
Qualifications
Corrective and preventive actions
Oos and deviations
THE MASTER RECORD
Bill of materials
Approved vendors
Equipment needed
Procedures in detail
Raw material qc
In process qc
Finished goods qc Labels
Release procedure
-
8/12/2019 Schiff GMP Compliance Key Points
6/15
BUILDINGS AND FACILITIES
Receiving area
Security
Quarantine
Inspection
Sampling
Testing
Rejected material handling
BUILDINGS AND FACILITIES
CONTINUED
Warehouse
Arrangement
Labeling of items for status
Red, yellow, green
Segregation of goods
Separate raw, in process and finished
Separate regulated from non-regulated
Neatness counts Eliminate possibility for error
-
8/12/2019 Schiff GMP Compliance Key Points
7/15
BUILDINGS AND FACILITIES
CONTINUED
Manufacturing area
Staging
In-process storage
Line clearance
Blending
Filling
Packaging
BUILDINGS AND FACILITIES
CONTINUED
Shipping area
Holding area prior to release
Storage of released goods
Record keeping
Security
-
8/12/2019 Schiff GMP Compliance Key Points
8/15
BUILDINGS AND FACILITIES
CONTINUED
Utilities Water system
Testing routinely
Lighting
Maintenance
Pest control Record keeping
Verification
EQUIPMENT, CONTAINERS AND
PRODUCTION DOCUMENTS
Equipment
Design
For which it was intended
Location
Cross draft
Open doors
Materials
Extractables
Lubricants and coolants
Jacketed equipment
-
8/12/2019 Schiff GMP Compliance Key Points
9/15
EQUIPMENT, CONTAINERS AND
PRODUCTION DOCUMENTSCONTINUED
Equipment maintenance Mechanical equipment
Precision equipment
Automatic equipment
Electronic and computers
Calibration
Cleaning
Log books and records
EQUIPMENT, CONTAINERS AND
PRODUCTION DOCUMENTSCONTINUED
COMPUTERS
21CFR PART 11
VALIDATION OF COMPUTERS THAT
DRIVE OR RECORD PRODUCTION
PROCESSES SOFTWARE VALIDATION REQUIRED
-
8/12/2019 Schiff GMP Compliance Key Points
10/15
PRODUCTION AND DISTRIBUTION
CONTROLS
Raw materials
Receiving and quarantine
Inspection and testing
Approved and released
Rejected
Rework areas
PRODUCTION AND DISTRIBUTION
CONTROLS CONTINUED
Manufacturing
Preparation of equipment and sops
Assignment of control number
Records and entries
In-process testing
In-process storage
Batch adjustments
-
8/12/2019 Schiff GMP Compliance Key Points
11/15
PRODUCTION AND DISTRIBUTION
CONTROLS
Labeling and packaging Storage of labels
Label controls
Label accountability
Packaging lines
Packaging materials
Packaging equipment
Preparation of equipment
Sec. 211.84 Testing and approval or
rejection of components, drug productcontainers, and closures.
(a) Each lot of components, drug
product containers, and closures shall
be withheld from use until the lot has
been sampled, tested, or examined, as
appropriate, and released for use by thequality control unit.
-
8/12/2019 Schiff GMP Compliance Key Points
12/15
211.84 Continued
b) Representative samples of each shipment
of each lot shall be collected for testing or
examination. The number of containers to be
sampled, and the amount of material to be
taken from each container, shall be based
upon appropriate criteria such as statistical
criteria for component variability, confidence
levels, and degree of precision desired, thepast quality history of the supplier, and the
quantity needed for analysis and reserve
where required by 211.170.
PRODUCTION AND DISTRIBUTION
CONTROLS
Shipping and carton labels
Final testing
Delivery records
-
8/12/2019 Schiff GMP Compliance Key Points
13/15
SHIPPING AND HANDLING
Packaging
Temperature control
Temperature monitoring
Air versus ground shipping
Sample receipt
Data logging
STABILITY, EXPIRATION
DATING AND VALIDATION
Stability establishes dating
Stability testing is validation
Validation of expiration
Poolability of slopes
Poolability of intercepts
Confidence intervals
-
8/12/2019 Schiff GMP Compliance Key Points
14/15
VALIDATION AND QUALIFICATION
INTERPRETING REGULATORY
REQUIREMENTS
What are the differences between validation
and qualification
Equipment is qualified
Methods and processes are validated
Before a method can be validated the
associated equipment must be qualified
WHAT TO DO
Qualification and Validation
Equipment
Processes
Water
Clean Rooms
Facilities
Cleaning
-
8/12/2019 Schiff GMP Compliance Key Points
15/15
THINGS TO REMEMBER
Review on a Daily Basis
Take Notes
Differentiate Between Guidelines andRegulations
Inform Management of Changes
Know Your Source
Do Not Always Accept on the Basis of
Certification Never Accept on Supposition